Christopher G. Pierce

3.8k total citations · 2 hit papers
24 papers, 3.1k citations indexed

About

Christopher G. Pierce is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Christopher G. Pierce has authored 24 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 13 papers in Epidemiology and 11 papers in Molecular Biology. Recurrent topics in Christopher G. Pierce's work include Antifungal resistance and susceptibility (22 papers), Fungal Infections and Studies (13 papers) and Bacterial biofilms and quorum sensing (11 papers). Christopher G. Pierce is often cited by papers focused on Antifungal resistance and susceptibility (22 papers), Fungal Infections and Studies (13 papers) and Bacterial biofilms and quorum sensing (11 papers). Christopher G. Pierce collaborates with scholars based in United States, Mexico and Brazil. Christopher G. Pierce's co-authors include José L. López-Ribot, Priya Uppuluri, Floyd L. Wormley, Eilidh Mowat, Anne Tristan, Gordon Ramage, Stephen P. Saville, Anand K. Ramasubramanian, Anna L. Lazzell and Jesús A. Romo and has published in prestigious journals such as Nature Protocols, Antimicrobial Agents and Chemotherapy and Molecular Biology of the Cell.

In The Last Decade

Christopher G. Pierce

24 papers receiving 3.1k citations

Hit Papers

A simple and reproducible 96-well plate-based method for ... 2008 2026 2014 2020 2008 2008 200 400 600

Peers

Christopher G. Pierce
Eilidh Mowat United Kingdom
Christopher G. Pierce
Citations per year, relative to Christopher G. Pierce Christopher G. Pierce (= 1×) peers Eilidh Mowat

Countries citing papers authored by Christopher G. Pierce

Since Specialization
Citations

This map shows the geographic impact of Christopher G. Pierce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher G. Pierce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher G. Pierce more than expected).

Fields of papers citing papers by Christopher G. Pierce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher G. Pierce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher G. Pierce. The network helps show where Christopher G. Pierce may publish in the future.

Co-authorship network of co-authors of Christopher G. Pierce

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher G. Pierce. A scholar is included among the top collaborators of Christopher G. Pierce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher G. Pierce. Christopher G. Pierce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Romo, Jesús A., et al.. (2018). In Vitro Characterization of a Biaryl Amide Anti-virulence Compound Targeting Candida albicans Filamentation and Biofilm Formation. Frontiers in Cellular and Infection Microbiology. 8. 227–227. 14 indexed citations
2.
Romo, Jesús A., Christopher G. Pierce, Ashok K. Chaturvedi, et al.. (2017). Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of Candida albicans Filamentation. mBio. 8(6). 89 indexed citations
3.
Garner, Robert N., et al.. (2017). Photoinitiated treatment of Mycobacterium using Ru(II) isoniazid complexes. Inorganica Chimica Acta. 461. 261–266. 23 indexed citations
4.
Pierce, Christopher G., Taissa Vila, Jesús A. Romo, et al.. (2017). The Candida albicans Biofilm Matrix: Composition, Structure and Function. Journal of Fungi. 3(1). 14–14. 114 indexed citations
5.
Lara, Humberto H., et al.. (2015). Effect of silver nanoparticles on Candida albicans biofilms: an ultrastructural study. Journal of Nanobiotechnology. 13(1). 91–91. 251 indexed citations
6.
Pierce, Christopher G., Anand Srinivasan, Anand K. Ramasubramanian, & José L. López-Ribot. (2015). From Biology to Drug Development: New Approaches to Combat the Threat of Fungal Biofilms. Microbiology Spectrum. 3(3). 26 indexed citations
7.
Pierce, Christopher G., Ashok K. Chaturvedi, Anna L. Lazzell, et al.. (2015). A novel small molecule inhibitor of Candida albicans biofilm formation, filamentation and virulence with low potential for the development of resistance. npj Biofilms and Microbiomes. 1(1). 98 indexed citations
9.
Pierce, Christopher G., Stephen P. Saville, & José L. López-Ribot. (2014). High-content phenotypic screenings to identify inhibitors ofCandida albicansbiofilm formation and filamentation. Pathogens and Disease. 70(3). 423–431. 24 indexed citations
10.
Pierce, Christopher G. & José L. López-Ribot. (2013). Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs. Expert Opinion on Drug Discovery. 8(9). 1117–1126. 125 indexed citations
11.
Pierce, Christopher G., Anand Srinivasan, Priya Uppuluri, Anand K. Ramasubramanian, & José L. López-Ribot. (2013). Antifungal therapy with an emphasis on biofilms. Current Opinion in Pharmacology. 13(5). 726–730. 127 indexed citations
12.
Uppuluri, Priya, et al.. (2013). In Vitro Study of Sequential Fluconazole and Caspofungin Treatment against Candida albicans Biofilms. Antimicrobial Agents and Chemotherapy. 58(2). 1183–1186. 31 indexed citations
13.
Pierce, Christopher G., et al.. (2010). A 96 Well Microtiter Plate-based Method for Monitoring Formation and Antifungal Susceptibility Testing of <em>Candida albicans</em> Biofilms. Journal of Visualized Experiments. 90 indexed citations
14.
Uppuluri, Priya, Christopher G. Pierce, Derek P. Thomas, et al.. (2010). The Transcriptional Regulator Nrg1p Controls Candida albicans Biofilm Formation and Dispersion. Eukaryotic Cell. 9(10). 1531–1537. 82 indexed citations
15.
Pierce, Christopher G., et al.. (2009). Biofilm Formation by Cryptococcus neoformans Under Distinct Environmental Conditions. Mycopathologia. 167(6). 307–314. 30 indexed citations
16.
Lazzell, Anna L., Atul Chaturvedi, Christopher G. Pierce, et al.. (2009). Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasis. Journal of Antimicrobial Chemotherapy. 64(3). 567–570. 85 indexed citations
17.
Banerjee, Mohua, Anna L. Lazzell, Patricia L. Carlisle, et al.. (2008). UME6, a Novel Filament-specific Regulator ofCandida albicansHyphal Extension and Virulence. Molecular Biology of the Cell. 19(4). 1354–1365. 211 indexed citations
18.
Pierce, Christopher G., Priya Uppuluri, Anne Tristan, et al.. (2008). A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nature Protocols. 3(9). 1494–1500. 674 indexed citations breakdown →
19.
Pierce, Christopher G., Derek P. Thomas, & José L. López-Ribot. (2008). Effect of tunicamycin on Candida albicans biofilm formation and maintenance. Journal of Antimicrobial Chemotherapy. 63(3). 473–479. 43 indexed citations
20.
Pierce, Christopher G., Priya Uppuluri, Anne Tristan, et al.. (2008). A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nature Protocols. 3(9). 1494–1500. 720 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026